Intragastric balloon treatment for obesity: Results of a large single center prospective study

Obesity Surgery

Volumn 21, Issue 5, 2011, Pages 551-555

  Štimac, Davor ^a   Klobučar Majanović, Sanja ^a   Turk, Tamara ^a   Kezele, Borivoj ^a   Licul, Vanja ^a   Crnčević Orlić, Željka ^a  

^a KBC RIJEKA   (Croatia)

Author keywords

BIB; Bioenteric intragastric balloon; Cardiovascular risk; Fatty liver; Obesity; Weight loss

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SILASTIC; TRIACYLGLYCEROL;

ABDOMINAL DISCOMFORT; ADULT; ANTHROPOMETRY; ARTICLE; BALLOON DILATATION; BIOCHEMISTRY; BLOOD PRESSURE REGULATION; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; ESOPHAGOGASTRODUODENOSCOPY; FEMALE; GLYCEMIC CONTROL; HUMAN; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; NAUSEA AND VOMITING; OBESITY; PATIENT SAFETY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK REDUCTION; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

ADULT; BODY MASS INDEX; FEMALE; GASTRIC BALLOON; HUMANS; INSULIN RESISTANCE; LIVER; MALE; MIDDLE AGED; OBESITY, MORBID; PROSPECTIVE STUDIES; WEIGHT LOSS;

EID: 79955740911     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11695-010-0310-0     Document Type: Article

References (28)

1. WP James 2008 The epidemiology of obesity: the size of the problem J Intern Med 263 336 52 18312311 10.1111/j.1365-2796.2008.01922.x 1:STN:280:DC%2BD1c7msFaltg%3D%3D (Pubitemid 351342683)
2. K Fister I Kolcić SM Milanović, et al. 2009 The prevalence of overweight, obesity and central obesity in six regions of Croatia: results from the Croatian Adult Health Survey Coll Antropol 33 Suppl 1 25 9 19563142
3. KR Fontaine DT Redden C Wang, et al. 2003 Years of life lost due to obesity JAMA 289 187 93 12517229 10.1001/jama.289.2.187 (Pubitemid 36068706)
4. P Poirier TD Giles GA Bray, et al. 2006 Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss Circulation 113 898 918 16380542 10.1161/CIRCULATIONAHA.106.171016
5. D Rucker R Padwal SK Li, et al. 2007 Long term pharmacotherapy for obesity and overweight: updated meta-analysis BMJ 335 1194 9 18006966 10.1136/bmj.39385.413113.25 1:CAS:528:DC%2BD1cXhtFKlsLo%3D (Pubitemid 350273303)
6. M Li BM Cheung 2009 Pharmacotherapy for obesity Br J Clin Pharmacol 68 6 804 10 20002075 10.1111/j.1365-2125.2009.03453.x 1:CAS:528: DC%2BC3cXkvFOrsQ%3D%3D
7. MJ Bult T van Dalen AF Muller 2008 Surgical treatment of obesity Eur J Endocrinol 158 135 45 18230819 10.1530/EJE-07-0145 1:CAS:528: DC%2BD1cXisFygur8%3D (Pubitemid 351298529)
8. LB Goldfeder CJ Ren JR Gill 2005 Fatal complications of bariatric surgery Obes Surg 16 1050 6 10.1381/096089206778026325 (Pubitemid 44221271)
9. N Tsesmeli D Coumaros 2009 Review of endoscopic devices for weight reduction: old and new balloons and implantable prostheses Endoscopy 41 1082 9 19899029 10.1055/s-0029-1215269 1:STN:280:DC%2BD1MfgvFagug%3D%3D
10. Fernandes M, Atallah AN, Soares BG, et al. Intragastric balloon for obesity. Cochrane Database Syst Rev. 2007;(1):CD004931.
11. H Alfalah B Phillipe F Ghazal 2006 Intragastric balloon for preoperative weight reduction in candidates for laparoscopic gastric bypass with massive obesity Obes Surg 16 147 50 16469215 10.1381/096089206775565104
12. MD Frutos MD Morales J Lujan, et al. 2007 Intragastric balloon reduces liver volume in super-obese patients, facilitating subsequent laparoscopic gastric bypass Obes Surg 17 150 4 17476864 10.1007/s11695-007-9040-3 (Pubitemid 47091574)
13. S Zago AM Kornmuller D Agagliati, et al. 2006 Benefit from bio-enteric intra-gastric balloon (BIB) to modify lifestyle and eating habits severely obese patients eligible for bariatric surgery Minerva Med 97 51 64 16565699 1:STN:280:DC%2BD283nsVaktA%3D%3D (Pubitemid 43667174)
14. DJ Goldstein 1992 Beneficial health effects of modest weight loss Int J Obes Relat Metab Disord 16 397 415 1322866 1:STN:280:DyaK38zlsFWruw%3D%3D
15. J Herve CH Wahlen A Schaeken, et al. 2005 What becomes of patients one year after intragastric balloon removed? Obes Surg 15 864 70 15978160 10.1381/0960892054222894 1:STN:280:DC%2BD2MzjtVWqtA%3D%3D (Pubitemid 40904880)
16. JA Sallet JB Marchesini DS Paiva, et al. 2004 Brazilian multicenter study of the intragastric balloon Obes Surg 14 991 8 15329191 10.1381/ 0960892041719671 (Pubitemid 39093476)
17. Lopez-Nava G, Rubio MA, Prados S, et al. BioEnterics intragastric balloon (BIB). Single ambulatory Spanish experience with 714 consecutive patients treated with one or two consecutive balloons. Obes Surg. 2010; in press.
18. R Ganesh AD Rao HG Baladas, et al. 2007 The bioenteric intragastric balloon (BIB) as a treatment for obesity: poor results in Asian patients Singapore Med J 48 227 31 17342292 1:STN:280:DC%2BD2s7kt1Cmug%3D%3D (Pubitemid 351229391)
19. EM Mathus-Vliegen GN Tytgat 2005 Intragastric balloon for treatment-resistant obesity: safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon-free follow-up Gastrointest Endosc 61 19 27 15672051 10.1016/S0016-5107(04)02406-X (Pubitemid 40169806)
20. NS Dastis E Francois J Deviere, et al. 2009 Intragastric balloon for weight loss: results in 100 individuals followed for at least 2.5 years Endoscopy 41 7 608 11 10.1055/s-0029-1214889
21. E Machytka P Klvana l Hanuskova, et al. 2007 Use of pharmacotherapy for long-term maintenance of weight loss following explantation of intragastric balloon (BIB) Gut 57 A290
22. KG Alberti PZ Zimmet J Shaw 2005 The metabolic syndrome-a new worldwide definition Lancet 366 1059 62 16182882 10.1016/S0140-6736(05)67402-8 (Pubitemid 41338752)
23. E Bugianesi AJ McCullogh G Marchesini 2005 Insulin resistance: a metabolic pathway to chronic liver disease Hepatology 42 987 1000 16250043 10.1002/hep.20920 1:CAS:528:DC%2BD2MXht1amtb3E (Pubitemid 43112663)
24. TM Wallace KM Utzschneider J Tong, et al. 2007 Relationship of liver enzymes to insulin sensitivity and intra-abdominal fat Diabetes Care 30 2673 8 17666458 10.2337/dc06-1758 1:CAS:528:DC%2BD2sXht1CltrnK (Pubitemid 47547819)
25. G Marchesini S Avagnina EG Barantani, et al. 2005 Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome J Endocrinol Invest 28 333 9 15966506 1:CAS:528:DC%2BD2MXlslWnsbg%3D (Pubitemid 43162752)
26. Y Chang S Ryu E Sung, et al. 2007 Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease Clin Chem 53 686 92 17272484 10.1373/clinchem.2006.081257 1:CAS:528:DC%2BD2sXksFWhtbo%3D (Pubitemid 46580239)
27. G Ricci G Bersani A Rossi, et al. 2008 Bariatric therapy with intragastric balloon improves liver dysfunction and insulin resistance in obese patients Obes Surg 18 1438 42 18369681 10.1007/s11695-008-9487-x
28. M Konopko-Zubrzycka I Kowalska E Wroblewski, et al. 2009 The effect of intragastric balloon on serum lipids level in patients with morbid obesity Pol Merkur Lekarski 26 155 430 4 19606690 1:STN:280:DC%2BD1MvovFOisw%3D%3D